ConMed Corp. (NYSE: CNMD), a surgical-device maker with roots in the Utica area, has announced that its board of directors declared a quarterly cash dividend of 20 cents a share for the second quarter of 2023. The dividend is payable on July 5 to all shareholders of record as of June 15. At the company’s […]
ConMed Corp. (NYSE: CNMD), a surgical-device maker with roots in the Utica area, has announced that its board of directors declared a quarterly cash dividend of 20 cents a share for the second quarter of 2023.
The dividend is payable on July 5 to all shareholders of record as of June 15. At the company’s current stock price, the dividend yields about 0.6 percent on an annual basis.
ConMed manufactures surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
ConMed, which was based in the Utica–Rome region for more than 50 years, at the beginning of 2021 designated Largo, Florida (in the Tampa Bay area) as its corporate headquarters Its Utica–area facility is located at 525 French Road in New Hartford, where the company continues to maintain its manufacturing, finance, human resources, legal, and other corporate functions. The Florida office houses its CEO and other key executives.